Sun Li-Fei, Yang Kun, Wang Yi-Gao, Liu Yu-Xin, Hou Pei-Xian, Lu Zheng-Hao, Chen Xiao-Long, Zhang Wei-Han, Zhou Zong-Guang, Mo Xian-Ming, Hu Jian-Kun
Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China.
Department of Gastrointestinal Surgery, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Front Oncol. 2020 Aug 21;10:1608. doi: 10.3389/fonc.2020.01608. eCollection 2020.
Deregulation of HER2 expression could affect the biological characteristics of gastric cancer cells and treatment option for gastric cancer patients. This research aims to investigate the impact of HER2 on biological characteristics of gastric cancer stem cells (GCSCs) and prognosis of gastric cancer patients.
HER2 knockdown in GCSCs were constructed by lentivirus transfection. Alterations of proliferation, self-renewal, invasion, migration, colony formation, and tumorigenicity of GCSCs were examined. The changes of gene expressions after HER2 interference in GCSCs were detected by gene microarray. The impact of concentration of serum HER2 and expression of HER2 in tumor tissues on survival of 213 gastric cancer patients was also analyzed.
Down-regulation of HER2 decreased the self-renewal, colony formation, migration, invasion, proliferation, and chemotherapy resistance of GCSCs. However, the tumorigenicity of GCSCs was increased after down-regulation of HER2. The results of gene microarray showed that HER2 gene might regulate the signal transduction of mTOR, Jak-STAT, and other signal pathways and affect the biological characteristics of GCSCs. Furthermore, survival analyses indicated that patients with high concentration of HER2 in serum had a favorable overall survival. However, there was no significant correlation between expression of HER2 in tumor tissue and overall survival.
Interference of HER2 in GCSCs decreased the capacity of self-renewal, proliferation, colony formation, chemotherapy resistance, invasion, and migration but might increase the tumorigenicity . Patients with high concentration of HER2 in serum seemed to have a favorable prognosis.
HER2表达失调可能影响胃癌细胞的生物学特性及胃癌患者的治疗选择。本研究旨在探讨HER2对胃癌干细胞(GCSCs)生物学特性及胃癌患者预后的影响。
通过慢病毒转染构建GCSCs中HER2基因敲低模型。检测GCSCs增殖、自我更新、侵袭、迁移、集落形成及致瘤性的变化。采用基因芯片检测GCSCs中HER2干扰后基因表达的变化。分析213例胃癌患者血清HER2浓度及肿瘤组织中HER2表达对生存的影响。
HER2下调降低了GCSCs的自我更新、集落形成、迁移、侵袭、增殖及化疗耐药性。然而,HER2下调后GCSCs的致瘤性增加。基因芯片结果显示,HER2基因可能调控mTOR、Jak-STAT等信号通路的信号转导,影响GCSCs的生物学特性。此外,生存分析表明,血清HER2浓度高的患者总生存期良好。然而,肿瘤组织中HER2表达与总生存期之间无显著相关性。
干扰GCSCs中的HER2可降低其自我更新、增殖、集落形成、化疗耐药、侵袭及迁移能力,但可能增加其致瘤性。血清HER2浓度高的患者似乎预后良好。